- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06731309
HS ABSCESSES: I&D VS PUNCH DEBRIDEMENT (HSPUNCH)
December 9, 2024 updated by: Hessel H van der Zee, MD, PhD, Erasmus Medical Center
ABSCESS DRAINAGE in HIDRADENITIS SUPPURATIVA: INCISION and DRAINAGE VERSUS PUNCH DEBRIDEMENT
This randomized-control trial is designed to determine the recurrence rate of HS abscesses following drainage via two methods: I&D with a linear incision and PD with an 8mm punch biopsy.
In this context, recurrence is a newly described HS abscess adjacent to or within the previously operated area, for which a second intervention is deemed necessary.
We hypothesize that PD may yield a more favorable recurrence rate.
In addition to comparing recurrence rates, this randomized-control trial will also evaluate postprocedural pain, the occurrence and type of complications, and patients' quality of life associated with both procedures.
These additional factors are crucial in assessing the overall effectiveness and patient satisfaction associated with each method, further informing the potential establishment of PD as the new gold standard for draining small, painful, acute HS abscesses.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
72
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hessel H van der Zee, MD, PhD
- Phone Number: +31 10 704 0110
- Email: h.vanderzee@erasmusmc.nl
Study Locations
-
-
Zuid-Holland
-
Rotterdam, Zuid-Holland, Netherlands
- Erasmus MC
-
Contact:
- Hessel H van der Zee
- Phone Number: +31 10 704 0110
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosed with HS
- Has an abscess requiring drainage with a maximum diameter of 5 centimeters.
- Age 16 years or older
- Willing and able to provide informed consent
Exclusion Criteria:
- Has other conditions that could interfere with the study, as estimated by physician
- Unable to comply with follow-up visits
- Allergic to lidocaine and/or adrenaline.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Punch Debdridement
After local anesthesia, a punch biopsy tool is positioned over the inflamed follicular unit, and a small circle of skin (4 to 8 mm in diameter) is excised.
A firm twisting motion is necessary to ensure adequately deep excision.
Similar to I&D, this is followed by applying digital pressure and gauze scraping to eliminate the fluid contents.
The wound is then left open to allow free drainage and heal by secondary intention.
|
A punch biopsy tool is positioned over the inflamed follicular unit, and a small circle of skin (4 to 8 mm in diameter) is excised.
A firm twisting motion is necessary to ensure adequately deep excision.
|
|
Active Comparator: Gold standard: Incision and Drainage
Incision and Drainage is a minimally invasive surgical procedure often employed for the treatment of intensely painful, tense, and fluctuant abscesses that are too deep to drain spontaneously.
After administration of a broad circumferential local anesthetic, a small linear incision is made using a standard scalpel blade.
Digital pressure is applied to expel the fluid collection.
Saline rinses can be used to flush out the remaining contents.
This method offers instant pain relief, commonly performed in acute settings by dermatologists, emergency department physicians and general practitioners.
|
Incision and Drainage is a minimally invasive surgical procedure often employed for the treatment of intensely painful, tense, and fluctuant abscesses that are too deep to drain spontaneously.
After administration of a broad circumferential local anesthetic, a small linear incision is made using a standard scalpel blade.
Digital pressure is applied to expel the fluid collection.
Saline rinses can be used to flush out the remaining contents.
This method offers instant pain relief, commonly performed in acute settings by dermatologists, emergency department physicians and general practitioners
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recurrence
Time Frame: 1 month
|
Recurrence rate in percentage of abscesses recurring after drainage
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
February 1, 2025
Primary Completion (Estimated)
April 1, 2026
Study Completion (Estimated)
April 1, 2027
Study Registration Dates
First Submitted
December 9, 2024
First Submitted That Met QC Criteria
December 9, 2024
First Posted (Estimated)
December 12, 2024
Study Record Updates
Last Update Posted (Estimated)
December 12, 2024
Last Update Submitted That Met QC Criteria
December 9, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EMCD_12304
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hidradenitis Suppurativa (Acne Inversa)
-
Peking Union Medical CollegeNot yet recruitingHidradenitis Suppurativa (HS) | Secukinumab | Hidradenitis Suppurativa (Acne Inversa)China
-
Peking Union Medical CollegeRecruitingHidradenitis Suppurativa (HS) | Secukinumab | Hidradenitis Suppurativa (Acne Inversa)China
-
Yale UniversityWithdrawnHidradenitis Suppurativa | Hidradenitis Suppurativa, Acne Inversa | Hidradenitis Suppurativa \(HS\)United States
-
Erasmus Medical CenterNot yet recruitingHidradenitis Suppurativa, Acne Inversa
-
Novartis PharmaceuticalsCompletedHidradenitis Suppurativa (Acne Inversa)United States, Denmark, Germany, Netherlands, Switzerland
-
Janssen Research & Development, LLCCompletedHidradenitis Suppurativa | Acne Inversa | Suppurative HidradenitisUnited States
-
University of North Carolina, Chapel HillAstraZenecaActive, not recruitingHidradenitis Suppurativa | Hidradenitis | Acne InversaUnited States
-
Incyte CorporationCompletedHidradenitis Suppurativa | Acne InversaUnited States, Canada, France, Germany, Poland, Spain
-
AmgenCompletedHidradenitis Suppurativa | Acne InversaUnited States
-
PfizerCompletedAcne InversaUnited States, Australia, Canada
Clinical Trials on Punch Debridement
-
Smith & Nephew, Inc.TerminatedTorn MeniscusUnited States
-
M.D. Anderson Cancer CenterUnited States Department of DefenseCompletedMelanoma | Sarcoma | Breast Cancer | Malignant Female Reproductive System Neoplasm | Genitourinary CancerUnited States
-
Duke UniversityTerminated
-
Tampere University HospitalOlfactomics OyRecruitingOral Squamous Cell CarcinomaFinland
-
Tampere University HospitalOlfactomics OyRecruiting
-
Ohio State UniversityCompletedCellulitis | PseudocellulitisUnited States
-
Nova Scotia Health AuthorityWithdrawn
-
Maastricht University Medical CenterCompletedBasal Cell CarcinomaNetherlands
-
DEBx Medical B.V.Completed
-
Medaxis, LLCNAMSARecruitingDiabetic Foot Ulcer | Venous Leg Ulcer | Surgical Wound Dehiscence | Traumatic WoundsUnited States